📢 Out now: The September 2024 issue explores improved access to organ transplantation, a health equity index, global collaboration on patient-reported outcomes, clinical decision-making tools, integration of teaching and research into community practices, longitudinal care management, and patient quality and safety. 📖 View the issue: https://nej.md/3YTnvA5 🎧 Read or listen to the editor letter: Novel Approaches and Actionable Insights to Improve Outcomes: https://nej.md/3yTEYNU 📊 Insights Report: Quality and Patient Safety Improvement Is Never Finished: https://nej.md/3X5dK0d with expert advisors Allen Kachalia, Johns Hopkins Medicine, and Kris Vanhaecht, KU Leuven Institute for Healthcare Policy 🥼 In Depth: The African American Transplant Access Program: Mitigating Disparities in Solid Organ Transplantation: https://nej.md/46PL4LQ 📋 Case Study: A Physician-Created Platform to Speed Clinical Decision-Making and Referral Workflow: https://nej.md/3WNYWSj 👩⚕️ Case Study: The Journey to an Incentive-Based Health Equity Quality Index: https://nej.md/3yCbNyV 🏥 Article: How a Robust Community Clinical Practice Arm Can Support an Academic Health System’s Tripartite Mission: https://nej.md/3X9ZkuL ✔️ Article: Comparable Real-World Patient-Reported Outcomes Data Across Health Conditions, Settings, and Countries: The PROMIS International Collaboration: https://nej.md/4ct9EDI 🩸 Commentary: Longitudinal Care Management for Diabetes and Hypertension: https://nej.md/4dJn92R
About us
NEJM Catalyst brings health care executives, clinician leaders, and clinicians together to share innovative ideas and practical applications for enhancing the value of health care delivery.
- Website
-
http://catalyst.nejm.org
External link for NEJM Catalyst
- Industry
- Book and Periodical Publishing
- Company size
- 11-50 employees
- Headquarters
- Waltham, Massachusetts
- Founded
- 2015
Updates
-
Northwestern Medicine created a transplant access program to provide disadvantaged Black patients support in navigating the transplant evaluation process with a culturally congruent support team. The program expanded from kidney to all solid organs: https://nej.md/46PL4LQ
-
NEJM Catalyst Insights Council members largely rate their organizations’ quality and patient safety outcomes highly, but acknowledge many challenges: https://nej.md/3X5dK0d
-
Issue 5.9: Organ transplantation access, health equity index, patient-reported outcome global collaboration, clinical decision-making tools, teaching and research integrated into community practice, longitudinal care management, patient quality and safety: https://nej.md/3yTEYNU
-
NEJM Catalyst reposted this
Dana Gelb Safran, President and CEO, National Quality Forum, and Chief Scientific Officer, The Joint Commission, recently provided insights based on her experience as a former developer of patient experience measures at the event, "Patient-Centered Innovation: Key Steps for Clinicians, Purchasers & Payers." Read more in a new article in NEJM Catalyst: https://lnkd.in/gViRwX3x
Learn more about the evolution of patient experience measurement, the Alternative Quality Contract, and how patient experience measurement must change to meet patients' needs today from NQF President and CEO Dana Gelb Safran. Read the full article from NEJM Catalyst: https://nej.md/46I7iiM (subscription required)
-
NEJM Catalyst reposted this
The nature of population-level #health priorities has continuously evolved over the past century — spanning an emphasis on #sanitation and preventing #infectiousdisease, to combatting #obesity and chronic #cardiometabolic conditions, to the social factors driving #epidemics of #addiction, loneliness, and inequity. Each of these priorities are distinctly modifiable by the unique tools and expertise of both #clinical #medicine and public health, yet the two disciplines have long operated in predominantly separate spaces. This article by the NEJM Catalyst explores and breaks down how #Population health, as a discipline, is rooted in identifying the most pressing health outcomes and developing coordinated strategies across diverse stakeholders and skill sets — be they based in #clinical, #publichealth, #socialpolicy, or elsewhere — to optimise impact. Source: https://lnkd.in/dA4bx_Ze
-
NEJM Catalyst invites you to a free virtual event September 18, 2024, 12-2pm ET: "Gen AI and Health IT: Debunking Myths and Embracing Innovation." Learn how to use generative AI to truly improve care delivery, separate the "bright and shiny objects" of technology from real opportunities, and address the pain points like electronic health record overload and cybersecurity vulnerabilities. Register today: https://nej.md/3M7HLWI #NEJMCatLive Optum
-
Volume 5, Number 9, the September 2024 of NEJM Catalyst Innovations in Care Delivery, is now available: https://nej.md/3YTnvA5
-
Addressing common sources of chronic disease leads to improved patient health, as well as presenting a scalable target for the improvement of value-based care outcomes. Improving patients’ self-management skills and quality of life is the key goal of chronic disease management. Mitigating high-costs and slowing disease progression create mutual success for both patients and health care systems. By training nurses to deliver a refined model of longitudinal care management, Corewell Health West was able to achieve improved chronic disease control and create additional capacity among primary care providers. The initial focus of the longitudinal care program was diabetes and hypertension management. Corewell Health created a Multidisciplinary Approach to Disease Over Time (MADOT) framework to guide care management for patients with multiple chronic conditions or who are facing long recovery journeys. The framework emphasizes timely and actionable patient identification, regular contact between patients and health care staff that prioritizes patient goals and assesses their “readiness to change,” and specialized skills development for health care staff. The framework has shown success among patients with uncontrolled diabetes (A1c ≥8.0). Of the targeted interventions carried out for more than 1,000 patients since January 2022, 608 patients fully completed the program; these patients demonstrated an average 2.24-percentage point reduction in hemoglobin A1c. Of those 608 patients, 364 had a pre-intervention hemoglobin A1c level ≥9.0 and achieved an average 3.02-percentage point reduction in hemoglobin A1c. Similarly, patients who graduated from the program saw greater improvement in systolic blood pressure than patients who disenrolled or declined interventions: https://nej.md/4dJn92R Erica Auger, LMSW, Sarah Varney Fisher, MSN, RN, Tricia Baird MD FAAFP MBA, Corewell Health
-
NEJM Catalyst reposted this
Learn more about the evolution of patient experience measurement, the Alternative Quality Contract, and how patient experience measurement must change to meet patients' needs today from NQF President and CEO Dana Gelb Safran. Read the full article from NEJM Catalyst: https://nej.md/46I7iiM (subscription required)